In this study, we found that PP242 alleviates the claudin-2 increase and tight junction function impairment in TNF-α treated cell monolayers via autophagy-lysosome pathway, which may partly explain its therapeutic effect in IBD. Here, CLDN2 is linked to inflammatory bowel disease.